✦ LIBER ✦

O61 EFFICACY AND SAFETY OF MK-5172 AND MK-8742 ± RIBAVIRIN IN HEPATITIS C GENOTYPE 1 INFECTED PATIENTS WITH CIRRHOSIS OR PREVIOUS NULL-RESPONSE: THE C-WORTHY STUDY

✍ Scribed by Lawitz, E.; Hezode, C.; Gane, E.; Tam, E.; Lagging, M.; Balart, L.; Rossaro, L.; Ghalib, R.; Shaughnessy, M.; Hwang, P.; Wahl, J.; Robertson, M.N.; Haber, B.

Book ID: 122129859
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 79 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60063-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O10 SAFETY AND EFFICACY OF THE ALL-ORAL

O10 SAFETY AND EFFICACY OF THE ALL-ORAL REGIMEN OF MK-5172/MK-8742 ± RIBAVIRIN IN TREATMENT-NAIVE, NON-CIRRHOTIC, PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: THE C-WORTHY STUDY

✍ Hezode, C.; Serfaty, L.; Vierling, J.M.; Kugelmas, M.; Pearlman, B.; Sievert, W. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

O63 EFFICACY AND SAFETY OF THE ALL-ORAL

O63 EFFICACY AND SAFETY OF THE ALL-ORAL REGIMEN, MK-5172/MK-8742 +/− RBV FOR 12 WEEKS IN GT1 HCV/HIV CO-INFECTED PATIENTS: THE C-WORTHY STUDY

✍ Sulkowski, M.; Mallolas, J.; Pol, S.; Bourliere, M.; Gerstoft, J.; Shibolet, O.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P1233 EFFICACY AND SAFETY OF MK-5172 PLU

P1233 EFFICACY AND SAFETY OF MK-5172 PLUS RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: FINAL RESULTS OF THE C-SPIRIT STUDY

✍ Gane, E.; Ben Ari, Z.; Mollison, L.; Zuckerman, E.; Bruck, R.; Baruch, Y.; Wahl, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

P1234 SAFETY AND EFFICACY OF MK-5172 PLU

P1234 SAFETY AND EFFICACY OF MK-5172 PLUS PEGINTERFERON ALFA-2b AND RIBAVIRIN (PR) IN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE (G)1 INFECTION

✍ Hezode, C.; Bruno, S.; Jacobson, I.; Serfaty, L.; Kwo, P.; Zhou, A.; Gilbert, C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

1197 MK-5172 IN COMBINATION WITH PEG-INT

1197 MK-5172 IN COMBINATION WITH PEG-INTERFERON/RIBAVIRIN DEMONSTRATES ROBUST EFFICACY AND A LOW RATE OF RESISTANCE-ASSOCIATED VIROLOGIC FAILURE IN TREATMENT NAÏVE GENOTYPE 1 CHRONIC HCV-INFECTED PATIENTS

✍ Howe, A.; Ludmerer, S.; Liu, R.; Black, S.; Barnard, R.; Newhard, W.; Graham, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

1208 EVALUATION OF NS3 AMINO ACID VARIAN

1208 EVALUATION OF NS3 AMINO ACID VARIANTS IN A PHASE 1B STUDY OF GENOTYPE 1 (GT1) AND GT3 INFECTED PATIENTS WITH THE HCV PROTEASE INHIBITOR, MK-5172

✍ Strizki, J.M.; Barnard, R.J.O.; Cheney, C.; McHale, C.; Graham, D.; Himmelberger 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB